Orally administered enalapril for infants with congestive heart failure: a dose-finding study (Q69335349)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2538615%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

title

Orally administered enalapril for infants with congestive heart failure: a dose-finding study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2538615%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

main subject

congestive heart failure

1 reference

1 reference

T R Lloyd

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2538615%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

L T Mahoney

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2538615%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

D Knoedel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2538615%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

W J Marvin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2538615%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

J E Robillard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2538615%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

R M Lauer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2538615%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

language of work or name

English

0 references

publication date

1 April 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2538615%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

30 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2538615%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

volume

114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2538615%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

issue

4 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2538615%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

page(s)

650-654

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2538615%20AND%20SRC:MED&resulttype=core&format=json

Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure

30 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980715-2

Treatment of congestive heart failure by altering loading conditions of the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980715-2

Significance of systemic vascular resistance in determining the hemodynamic effects of hydralazine on large ventricular septal defects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980715-2

Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980715-2

Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980715-2

Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980715-2

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980715-2

Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980715-2

Enalapril maleate and a lysine analogue (MK-521): disposition in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980715-2

Effects of enalapril, a new converting enzyme inhibitor, in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980715-2

The pharmacokinetics of enalapril in hospitalized patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980715-2

Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980715-2

Pharmacokinetics of repeated single oral doses of enalapril maleate (mk-421) in normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980715-2

Guidelines for vasodilator therapy of congestive heart failure in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980715-2

10.1016/S0022-3476(89)80715-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2538615%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

1 reference